.png){kind=logo}
A lead representative of Series 2 (KLS-219) shows the core architecture of this series.
A single ruthenium-nitrogen complex is bonded to two ligands, each of which can be varied to subtly alter the properties of these compounds.
With a distinct, and also novel, mode of action compared to Series 1 molecules, Series 2 compounds are dedicated to the development of antibacterial coatings and additives.
MetalloBio has generated proprietary formulations for use on catheters and other medical devices.